Picture of Ion Beam Applications SA logo

IBAB — Ion Beam Applications SA News Story

0.000.00%
be flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

IBA rises on improved proton therapy profitability

BUZZ-IBA rises on improved proton therapy profitability

** Shares in Belgian radiation therapy company IBA IBAB.BR rise 3.6% after what analysts see as good H1 results driven by its main proton therapy biz

** IBA's REBIT rises 66% y/y to €17.6 million ($20.51 million) driven by rapid improvement in proton therapy profitability

** IBA sold 5 proton therapy rooms in H1

** KBC notes a high net debt at €81 million but says the group is "on track" as it reiterates its guidance

** Including today's rise, the stock has gained 29.4% year-to-date

($1 = 0.8581 euros)


(Reporting by Lucie Barbier in Gdansk)

((lucie.barbier@thomsonreuters.com))

Recent news on Ion Beam Applications SA

See all news